TFF PHARMACEUTICALS, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-10-29: Reporting owner MILLS ROBERT S; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2019-10-29: Reporting owner Fletcher Aaron G.L.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2019-10-24: Reporting owner MILLS ROBERT S; Form 3; Security Series A preferred stock; Transaction Holding.
- 2019-10-24: Reporting owner Fletcher Aaron G.L.; Form 3; Security Series A preferred stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-10-29 | MILLS ROBERT S Director | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −10,980 184,023 owned after | no price filed | 2019-10-29 | |
| 2019-10-29 | Fletcher Aaron G.L. Director | 4 | Series A Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −43,919 135,806 owned after | no price filed | 2019-10-29 | |
| 2019-10-24 holding as of filing | MILLS ROBERT S Director | 3 | Series A preferred stock Derivative · Direct | Holding | no price filed | 2019-10-24 | ||
| 2019-10-24 holding as of filing | Fletcher Aaron G.L. Director | 3 | Series A preferred stock Derivative · Direct · (m) | Holding | no price filed | 2019-10-24 |